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Health outcomes research is aimed to “understand the end results of particular health care 
practices and interventions” [1], to inform the development of clinical guidelines, evaluate the 
quality of healthcare, and foster effective health interventions. It is, therefore, essential to 
have longitudinal information that encompasses the natural course of common diseases and 
the long-term outcomes of healthcare and treatments to promote evidence-based decision 
making. However, longitudinal studies are often punctuated by the presence of missing data 
which may compromise the representativeness of the sample and lead to biased results. 
Repeated-measures analysis of variance (rmANOVA) is widely used to analyse outcomes of 
longitudinal health-related studies, however it does not handle missing data and may 
influence the outcomes achieved. Generalized estimating equations (GEE) is a statistical 
method that belong to a class of semiparametric regression techniques and is less sensitive 
to variance structure specification. Although widely used in methodological areas, the GEE 
has been scarcely applied in clinical contexts. This study compares the results achieved 
using the rmANOVA and the GEE to analyse the time-course of clinical variables during 
acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and explore the 
factors influencing this recovery period. 
Methods 
A longitudinal observational study was conducted in non-hospitalised patients with AECOPD 
recruited from the urgent care of a Central Hospital. Approval was obtained from the ethics 
committee of the Centro Hospitalar do Baixo Vouga (13NOV’1514:40065682) and from the 
National Data Protection Committee (8828/2016). Written informed consent was obtained 
before data collection. 
Patients were asked to attend to four assessment sessions: within 48 hours of the urgent 
care visit (T0), and approximately 8 days (T1), 15 days (T2), and 45 days after the hospital 
visit (T3). At T0, the body mass index (BMI), the Charlson comorbidity index (CCI), the 
  
number of exacerbations in the previous year and the modified British Medical Research 
Council (mMRC) questionnaire for dyspnoea were collected (independent measures). 
Additionally, in each data collection moment, peripheral oxygen saturation (SpO2), forced 
expiratory volume in one second, in percentage of the predicted value (FEV1pp), the chronic 
obstructive pulmonary disease (COPD) assessment test (CAT) and the five-repetition sit-to-
stand test (5STS) were collected.  
Assumptions of the rmANOVA (i.e., multivariate normal distribution and sphericity) were 
evaluated with the Q-Q plots, for each variable, and the Mauchly's test of sphericity. 
Assumptions of the GEE (i.e., missingness at random) [2] were tested with the Little's 
missing completely at random (MCAR) test. Both methods were then applied to the data, 
acknowledging that the rmANOVA excludes subjects with at least one missing value. The 
GEE was used with a gamma link function and independent correlation structure. 
Results 
Forty-four non-hospitalised patients with AECOPD (31 males; 68±9 years; 51±20 FEV1pp) 
agreed to participate in the study. Using the rmANOVA, only patients that completed all 
measures were analysed, meaning that data from 36 participants were used for the CAT, 35 
for SPO2, 29 for the 5STS and 25 for the FEV1pp. Data from 44 patients were used when 
applying the GEE, except for the BMI covariate since data of 5 participants were missing. 
Assumptions for both statistical approaches were verified. 
Considering p<0.05 and p<0.01, consistency (i.e., both analysis provided simultaneously 
either significancy or not significancy) between the rmANOVA and the GEE was found in 
78% of the results (28/36 comparisons) and differences in 22% (8/36) of the results. From 
those, 5% (2/8) were detected as significant only by the rmANOVA and 17% (6/8) only by 
the GEE (tables 1 and 2). Considering p<0.01, consistency was found in 81% (29/36) of the 
results and differences in 19% (7/36) of the results. From those, 5% (2/7) were detected as 






Significant results were found using rmANOVA and GEE, however differences in the results 
obtained with both methods emerged. Previous studies have shown that GEE is more 
efficient than rmANOVA as it presents higher statistical power with smaller sample sizes and 
numbers of repeated measures [3], thus using a small sample size for the rmANOVA may 
have contributed for the different results achieved. Additionally, even with a high percentage 
of missing data (~70%), GEE estimates the effect under the outcome variable with smaller 
standard errors than analyses performed using the complete data only [4]. Nevertheless, the 
choice of the most adequate statistical approach to use should be based on the nature of 
  
data (i.e., missingness of random and normality of data) and aims of the analysis to be 
conducted. 
Conclusion 
The choice of the statistics method impacts on our understanding of the behaviour of clinical 
variables during AECOPD which ultimately may affect clinical decision-making and 
production of guidelines.  
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